EP2194951B1 - Device for introducing medicine into an infusion container - Google Patents
Device for introducing medicine into an infusion container Download PDFInfo
- Publication number
- EP2194951B1 EP2194951B1 EP20080802711 EP08802711A EP2194951B1 EP 2194951 B1 EP2194951 B1 EP 2194951B1 EP 20080802711 EP20080802711 EP 20080802711 EP 08802711 A EP08802711 A EP 08802711A EP 2194951 B1 EP2194951 B1 EP 2194951B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hollow
- container
- transfer cap
- infusion
- valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/2013—Piercing means having two piercing ends
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
Definitions
- the invention relates to a device for adding a medicament to an infusion solution in an infusion container according to the preamble of claim 1.
- a device of this kind is made US 5 647 845 A known, wherein on a cylindrical transfer cap on the outer circumference in the region of a transverse to the axis of the transfer cap inserted, rotatable valve body an angled pipe piece is attached, to which an infusion set can be connected.
- a connection can be established between the hollow mandrel attached to the transfer cap, which is inserted into the sealing area of an infusion container, and the angled tubular piece. At the exposed end of this pipe piece, contamination may occur during the handling of the device.
- infusion solution is first forced into the medicament container by repeatedly compressing the flexible infusion container.
- the assembly is rotated so that the infusion container at the bottom and the drug container is at the top, whereupon the contents of the drug container is sucked back into the infusion container by this again compressed and released several times.
- the drug container with transfer cap is removed from the infusion container and the infusion set attached to the infusion container, whereupon the infusion can begin.
- This procedure is associated with the risk of contamination of the infusion solution, because after removal of the medicament container, the removal opening of the infusion container is exposed and contaminating ambient air can penetrate into the infusion container.
- the invention has for its object to form a device of this kind so that the admixing of the drug for infusion without the risk of contamination.
- Another advantage is a simplification of handling, because the drug container does not need to be removed from the infusion container. As a result, the staff can read at any time on the basis of the drug container, which drug was added to the infusion solution.
- Fig. 1 shows a bottle-shaped infusion container 1, which usually consists of transparent plastic and flexible wall sections, so that the infusion container 1 can be compressed to generate a pressure in the container, whereupon by releasing a negative pressure is generated by the elastic side walls Reset.
- a bottleneck 1.2 On the lower side in the operating position of the infusion container is provided with a bottleneck 1.2, on which a transfer cap 2 is attached.
- 3 is a medicament container, usually a glass bottle, which is inserted with its axis oblique to the axis of the infusion container 1 in the transfer cap 2.
- 4 is a drip chamber of an infusion set, which is connected to the infusion container 1.
- Fig. 1 shows the operating position of the device in which an infusion is carried out, wherein the drip chamber 4 is arranged with its axis substantially parallel to the axis of the infusion container 1 or perpendicular and not oblique.
- Fig. 2 shows in a section a first embodiment of the transfer cap 2 in the in Fig. 1 reproduced operating position.
- a sealing cap 1.3 is attached fluid-tight, which is provided with a pierceable seal area 1.4.
- the transfer cap 2 via elastic latching sections 2.1 on a flange ( Fig. 1 ), which do not detachably overlap the edge of the sealing cap 1.3 without tools.
- Placed overhead flange with the catches 2.1 is followed by a substantially hollow cylindrical section 2.2 of the transfer cap, on the underside in Fig.
- a tubular approach 2.3 is formed so that its axis B is oblique to the axis A of the bottle neck 1.2 on the infusion container 1.
- This tubular approach 2.3 forms a receiving device for the drug container 3, which engages with its bottleneck 3.1 in this tubular approach 2.3.
- the tubular extension 2.3 is provided on its circumference with elastic hooks or notches 2.31, so that the provided with a flange or a crimp cap 3.1 of the medicine container 3 can engage in the tubular extension 2.3, whereupon the notches 2.31 the drug container 3 in the connecting position lock.
- the transfer cap 2 is provided on the side facing the infusion container 1 with a hollow mandrel 2.4, which pierces the sealing region 1.4 of the sealing cap 1.3, when the transfer cap 2 is attached to the bottle neck 1.2 of the infusion container 1.
- a further hollow dome 2.5 is arranged on the transfer cap 2 such that it forms a seal 3.2 of the medicament container 3 pierces when the drug container 3 is inserted into the tubular neck 2.3.
- a valve is arranged in the transfer cap 2, which interrupts the connection between the two hollow domes 2.4 and 2.5 and releases the connection only upon the action of an actuating force.
- the valve is designed as an elastic valve disc 5, which has three slots 5.1 in the middle region in a star shape.
- This valve disc 5 is clamped on the circumference between annular shoulders, wherein an annular shoulder is formed on a partition wall 2.7 of the transfer cap 2, on which the hollow mandrel 2.4 is formed, and the opposite annular shoulder is formed on the flange of an element provided with the hollow dome 2.5, as Separate component is used in this embodiment in the transfer cap 2 and in the region of the partition wall 2.7.
- the transfer cap 2 is laterally adjacent to the off-center and obliquely attached tubular approach 2.3 with a recess 2.6 ( Fig. 1 ), through which the sealing area 1.4 of the sealing cap 1.3 is exposed, so that the infusion set can be inserted with a hollow dome 4.1 at the drip chamber 4 through this recess 2.6 perpendicular to the sealing area 1.4.
- infusion solution can flow from the infusion container 1 through the hollow dome 4.1 in the drip chamber 4, while the valve disc 5 keeps the connection between the infusion container 1 and drug container 3 is closed.
- the transfer cap 2 with the tubular attachment 2.3 is first attached to the neck of the medicament container 3, so that the hollow mandrel 2.5 pierces the seal 3.2.
- the transfer cap 2 is connected to the medicament container 3 such that it can not be detached from the transfer cap 2 without a tool.
- the transfer cap 2 is attached to the sealed infusion container 1 with medicine container 3, so that the hollow mandrel 2.4 penetrates the seal area 1.4, as this Fig. 2a shows.
- the infusion container 1 may be positioned with the bottle neck on the top, so that the transfer cap 2 and the medicament container 3 are attached to the infusion container 1 from above.
- the closed valve 5 prevents it from leaking out of the medicament container 3.
- the arrangement is 180 ° in the in Fig. 2a rotated position reproduced, which is pressed by repeated compression of the flexible walls of the infusion container 1 infusion solution in the drug container 3.
- the valve disc 5 opens by bending between the slots 5.1 elastic valve lugs bend and allow a passage of infusion liquid to the drug container 3.
- the arrangement is again rotated 180 ° in the in Fig. 2b rotated position reproduced, whereupon by repeated compression of the infusion container 1, the infusion solution admixed drug from the drug container 3 is sucked into the infusion container 1.
- the valve disc 5 opens by the negative pressure generated in the infusion container 1 after releasing the compressed side walls of the infusion container. 1
- the hollow mandrel 4.1 of the drip chamber 4 is inserted through the recess 2.6 in the transfer cap 2 into the sealing area 1.4 of the infusion container 1, whereupon the infusion in the in Fig. 1 starting position reproduced.
- the connection between the drug container 3 and infusion container 1 is interrupted by the valve disc 5, because no forces acting on the valve disc 5. It can thus flow back no infusion solution in the underlying drug container 3.
- the medicine container 3 is not detachably connected to the transfer cap 2 and remains in the in Fig. 1 and 2 reproduced position on the transfer cap 2, as long as the infusion is performed.
- drug container 3 By remaining on the infusion device drug container 3 is immediately recognizable to the operator, which drug admixed to the infusion solution has been. Because the medicament container 3 is not released from the infusion container 1 or the transfer cap 2 after the mixing process, contamination in the connection area between the medicament container 3 and the infusion container 1 can not occur. After attaching the medicine container 3, the system remains closed.
- the arranged in the transfer cap 2 valve between the obliquely arranged and separated hollow domes 2.4 and 2.5, which ensures that the medicament container 3 need not be removed, can be formed in various ways.
- Fig. 3 shows a second embodiment with an actuatable by turning valve, wherein on the hollow mandrel 2.5, a valve disc 6 is formed, which is rotatably supported between detents on the partition wall 2.7 of the transfer cap 2 and eccentrically provided with a passage opening 6.1, with the mouth opening of the hollow dome 2.4 can be aligned.
- Fig. 3 shows the closed position of the valve disc 6, in which a closed area of the valve disc 6 of the mouth opening of the hollow dome 2.4 is opposite.
- Fig. 3a shows the connection position of the valve disc 6, in which the passage opening 6.1 is aligned with the hollow dome 2.4.
- valve disc 6 can be rotated with hollow mandrel 2.5 formed thereon, a positive connection between seal 3.2 and hollow mandrel 2.5 is expediently formed in that the hollow mandrel 2.5, for example, has an oval cross-section.
- the valve disc 6 can also be rotated into the open or closed position.
- Fig. 4 shows a third embodiment with a displaceable in the axial direction of the tubular extension 2.3 valve element 7.
- a neck 2.51 is formed on the hollow dome 2.5, which has a passage 2.52 ( Fig. 4a ), which can be closed and released by the displaceable valve element 7.
- Fig. 4 shows the closed position and the Fig. 4a the open position in which the sleeve-shaped valve element 7 is displaced in the direction of the medicament container 3, so that the passageway 2.52 is released.
- Fig. 5 shows a fourth embodiment of the valve between the obliquely arranged hollow mandrels 2.4 and 2.5 in the transfer cap 2, which has a rotatable valve body 8 with a protruding on the transfer cap 2 knob 8.1.
- the shaft-shaped valve body 8 is rotatable in a transverse bore of a lug on the hollow mandrel 2.5 and provided with a passage opening 8.2, which can be aligned with the hollow mandrel 2.5 and a connection opening to the hollow mandrel 2.4, when the knob 8.1 is rotated in the marked by a mark 8.11 open position , Fig. 5a shows the open position.
- the medicament container 3 is attached obliquely to the vertical in the operating position on the transfer cap 2, so that the flow path between the two hollow domes 2.4 and 2.5 can be kept as short as possible. But it is also possible to make the transfer cap 2 on the side of the medicament container 3 wider, so that the medicament container 3 can be positioned approximately perpendicular, ie with its axis B approximately parallel to the axis A of the infusion container 1. Although this results in a longer flow path between the two hollow domes 2.4 and 2.5 with the intermediate valve, but the flow path can be designed so that there is no interference with the mixing of the drug.
- a valve element between the two hollow mandrels can be provided, which is transversely displaceable to the axes A, B of the infusion container 1 and the medicament container 3 for opening and closing the connection between the two containers in the transfer cap 2.
- Fig. 6 shows the transfer cap 2 in various perspective views, wherein the hollow dome 2.5, which is formed on a separate component, which on the partition wall 2.7 (Fig. Fig. 6c ) is used in the Fig. 6b and 6c is not reproduced.
- Fig. 8 and 9 show such Two-part embodiment of the transfer cap 2, wherein at the bottom of the tubular neck 2.3 in Fig. 9 Recesses 2.32 are formed at diametrically opposite locations, the corresponding locking projections 2.33 record at the upper periphery of the hollow cylindrical sections 2.2 when the tubular projection 2.3 is attached to the section 2.2.
- Fig. 8 and 9 are the hollow domes 2.4 and 2.5 formed on the two elements 2.2 and 2.3 of the transfer cap 2, as this Fig. 8 shows.
- the hollow mandrel 2.5 is formed on a partition wall 2.51 in the tubular extension 2.3 in such a way that a chamber 2.52 results between the hollow dome 2.5 and the valve 5.
- 2.34 designated edge portion of the tubular extension 2.3 are in Fig. 9 reproduced recesses 2.32 formed.
- valve in the form of the valve disc 5 is clamped between the two elements 2.2 and 2.3 between the partitions 2.7 and 2.51.
- Fig. 8 and 9 are the in Fig. 2 reproduced notches 2.31 for receiving the medicament container 3 as a latching hook at opposite locations on the circumference of the tubular extension 2.3 formed as Fig. 9 shows.
- At the hollow cylindrical section 2.2 are instead of the opposite latching sections 2.1 in Fig. 6b in the Fig. 8 and 9 adjacent latching sections formed so that a total of four locking sections 2.1 result.
- the sealing area 1.4 at the removal opening of the infusion container 1 can be designed such that two adjacent sealing openings 1.41 and 1.42 are present in the cap 1.3, one of which is for the hollow dome 2.4 of the transfer cap 2 and the other for the hollow dome 4.1 of the drip chamber 4th is provided.
- Fig. 7 shows such a shaped, approximately rectangular sealing area 1.4 on the infusion container 1, wherein the border of the rectangular portion 1.4 is part of the sealing cap 1.3.
- an alignment device can be integrally formed on the transfer cap 2, by means of which the transfer cap 2 can only be attached to the infusion container 1 or to the sealing cap 1.3, that one of the openings 1.41, 1.42 under the recess 2.6 and the other is located under the hollow dome 2.4 of the transfer cap. In this way, incorrect positioning of the transfer cap 2 on the sealing cap 1.3 is prevented.
- the medicament container 3 and the drip chamber 4 are arranged so that they lie with their axes substantially in one plane, as this Fig. 1 shows. It is also an embodiment possible in which the medicament container 3 and thus also the tubular approach 2.3 obliquely to the plane in Fig. 1 is arranged so that in a side view from right or left in Fig. 2 the medicament container 3 obliquely to the drip chamber 4 and obliquely to the plane in Fig. 2 lies.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Closures For Containers (AREA)
Description
Die Erfindung betrifft eine Vorrichtung zum Zumischen eines Medikaments zu einer Infusionslösung in einem Infusionsbehälter nach dem Oberbegriff des Anspruchs 1.The invention relates to a device for adding a medicament to an infusion solution in an infusion container according to the preamble of
Eine Vorrichtung dieser Art ist aus
Bevor an einem Infusionsbehälter ein Infusionsbesteck mit Tropfkammer angebracht wird, um die Infusion auszuführen, ist es bekannt, der Infusionslösung ein Medikament derart beizumischen, dass auf der Entnahme-Öffnung des Infusionsbehälters eine Transferkappe mit einem Hohldom zum Durchstechen des Siegels am Infusionsbehälter aufgesetzt wird, die eine Aufnahmeeinrichtung für einen Medikamentenbehälter aufweist. Nach dem Verbinden des Infusionsbehälters mit dem Medikamentenbehälter wird zunächst Infusionslösung in den Medikamentenbehälter gedrückt, indem der flexible Infusionsbehälter wiederholt zusammengedrückt wird. Nach dem Auflösen und Zumischen des Medikaments zur Infusionslösung wird die Anordnung so gedreht, dass sich der Infusionsbehälter unten und der Medikamentenbehälter oben befindet, worauf der Inhalt des Medikamentenbehälters in den Infusionsbehälter zurückgesaugt wird, indem dieser wieder mehrmals zusammengedrückt und losgelassen wird. Danach wird der Medikamentenbehälter mit Transferkappe von dem Infusionsbehälter abgenommen und das Infusionsbesteck am Infusionsbehälter angebracht, worauf die Infusion beginnen kann.Before an infusion container with drip chamber is attached to carry out the infusion, it is known to mix the infusion solution, a drug such that on the removal opening of the infusion container, a transfer cap with a hollow dome for piercing the seal is placed on the infusion container, the a receiving device for a medicament container. After connecting the infusion container to the medicament container, infusion solution is first forced into the medicament container by repeatedly compressing the flexible infusion container. After dissolving and mixing the drug for solution for infusion, the assembly is rotated so that the infusion container at the bottom and the drug container is at the top, whereupon the contents of the drug container is sucked back into the infusion container by this again compressed and released several times. Thereafter, the drug container with transfer cap is removed from the infusion container and the infusion set attached to the infusion container, whereupon the infusion can begin.
Dieses Vorgehen ist mit der Gefahr einer Kontamination der Infusionslösung verbunden, weil nach dem Abnehmen des Medikamentenbehälters die Entnahme-Öffnung des Infusionsbehälters freiliegt und kontaminierende Umgebungsluft in den Infusionsbehälter eindringen kann.This procedure is associated with the risk of contamination of the infusion solution, because after removal of the medicament container, the removal opening of the infusion container is exposed and contaminating ambient air can penetrate into the infusion container.
Der Erfindung liegt die Aufgabe zugrunde, eine Vorrichtung dieser Art so auszubilden, dass das Zumischen des Medikaments zur Infusionslösung ohne die Gefahr einer Kontamination erfolgt.The invention has for its object to form a device of this kind so that the admixing of the drug for infusion without the risk of contamination.
Diese Aufgabe wird erfindungsgemäß durch die Merkmale des Anspruchs 1 gelöst. Dadurch, dass der Medikamentenbehälter nach dem Zumischen des Medikaments zur Infusionslösung nicht von der Transferkappe gelöst wird und die Infusion ausgeführt wird, während sich der Medikamentenbehälter am Infusionsbehälter befindet, wird das System geschlossen gehalten, sodass die Gefahr einer Kontamination der Infusionslösung vermieden wird.This object is achieved by the features of
Als weiterer Vorteil ergibt sich eine Vereinfachung der Handhabung, weil der Medikamentenbehälter nicht mehr vom Infusionsbehälter abgenommen zu werden braucht. Hierdurch kann das Personal anhand des Medikamentenbehälters jederzeit ablesen, welches Medikament zur Infusionslösung zugemischt wurde.Another advantage is a simplification of handling, because the drug container does not need to be removed from the infusion container. As a result, the staff can read at any time on the basis of the drug container, which drug was added to the infusion solution.
Die Erfindung wird beispielsweise anhand der Zeichnung näher erläutert. Es zeigen:
- Fig. 1
- in einer perspektivischen Ansicht den Infusionsbehälter mit Medikamentenbehälter und Tropfkammer im betriebsfertigen Zustand zum Ausführen einer Infusion,
- Fig. 2
- einen Schnitt durch die Vorrichtung mit einer Transferkappe nach einer ersten Ausführungsform,
- Fig. 3
- in der Schnittdarstellung nach
Fig. 2 eine zweite Ausführungsform, - Fig. 4
- in gleicher Darstellung eine dritte Ausführungsform,
- Fig. 5
- eine vierte Ausführungsform,
- Fig. 6
- perspektivische Darstellungen der Transferkappe,
- Fig. 7
- eine Ansicht des Infusionsbehälters,
- Fig. 8
- einen Längsschnitt durch eine abgewandelte Ausführungsform der Transferkappe, und
- Fig. 9
- eine perspektivische Ansicht der einzelnen Elemente der Ausführungsform nach
Fig. 8 .
- Fig. 1
- in a perspective view of the infusion container with drug container and drip chamber in the ready state for performing an infusion,
- Fig. 2
- a section through the device with a transfer cap according to a first embodiment,
- Fig. 3
- in the sectional view to
Fig. 2 a second embodiment, - Fig. 4
- in the same representation, a third embodiment,
- Fig. 5
- a fourth embodiment,
- Fig. 6
- perspective views of the transfer cap,
- Fig. 7
- a view of the infusion container,
- Fig. 8
- a longitudinal section through a modified embodiment of the transfer cap, and
- Fig. 9
- a perspective view of the individual elements of the embodiment according to
Fig. 8 ,
Im Bereich des rohrförmigen Ansatzes 2.3 ist die Transferkappe 2 auf der dem Infusionsbehälter 1 zugewandten Seite mit einem Hohldorn 2.4 versehen, der den Siegelbereich 1.4 der Siegelkappe 1.3 durchstößt, wenn die Transferkappe 2 auf den Flaschenhals 1.2 des Infusionsbehälters 1 aufgesteckt wird. Im Bereich dieses Hohldoms 2.4 ist an der Transferkappe 2 ein weiterer Hohldom 2.5 so angeordnet, dass er ein Siegel 3.2 des Medikamentenbehälters 3 durchstößt, wenn der Medikamentenbehälter 3 in den rohrförmigen Ansatz 2.3 eingesteckt wird.In the region of the tubular extension 2.3, the
Zwischen den beiden Hohldornen 2.4 und 2.5 ist in der Transferkappe 2 ein Ventil angeordnet, das die Verbindung zwischen den beiden Hohldomen 2.4 und 2.5 unterbricht und nur bei Einwirken einer Betätigungskraft die Verbindung freigibt.Between the two hollow mandrels 2.4 and 2.5, a valve is arranged in the
Bei der ersten Ausführungsform nach
Die Transferkappe 2 ist seitlich neben dem außermittig und schräg angesetzten rohrförmigen Ansatz 2.3 mit einer Ausnehmung 2.6 (
In dieser in
Zum Zumischen eines Medikaments zur Infusionslösung wird zunächst die Transferkappe 2 mit dem rohrförmigen Ansatz 2.3 auf den Hals des Medikamentenbehälters 3 aufgesteckt, so dass der Hohldorn 2.5 das Siegel 3.2 durchstößt. Hierbei wird die Transferkappe 2 so mit dem Medikamentenbehälter 3 verbunden, dass dieser ohne ein Werkzeug nicht von der Transferkappe 2 gelöst werden kann. Hierauf wird die Transferkappe 2 mit Medikamentenbehälter 3 auf den versiegelten Infusionsbehälter 1 aufgesteckt, sodass der Hohldorn 2.4 den Siegelbereich 1.4 durchstößt, wie dies
Hierauf wird die Anordnung um 180° in die in
Nachdem der Inhalt des Medikamentenbehälters 3 in den Infusionsbehälter 1 überführt ist, wird der Hohldorn 4.1 der Tropfkammer 4 durch die Ausnehmung 2.6 in der Transferkappe 2 in den Siegelbereich 1.4 des Infusionsbehälters 1 eingestochen, worauf die Infusion in der in
Durch den an der Infusionsvorrichtung verbleibenden Medikamentenbehälter 3 ist für das Bedienungspersonal sofort erkennbar, welches Medikament der Infusionslösung zugemischt wurde. Dadurch, dass der Medikamentenbehälter 3 nach dem Mischvorgang nicht vom Infusionsbehälter 1 bzw. der Transferkappe 2 gelöst wird, kann keine Kontamination im Verbindungsbereich zwischen Medikamentenbehälter 3 und Infusionsbehälter 1 auftreten. Nach dem Aufstecken des Medikamentenbehälters 3 bleibt das System geschlossen.By remaining on the infusion
Das in der Transferkappe 2 angeordnete Ventil zwischen den schräg zueinander angeordneten und voneinander getrennten Hohldomen 2.4 und 2.5, das gewährleistet, dass der Medikamentenbehälter 3 nicht abgenommen zu werden braucht, kann in verschiedener Weise ausgebildet werden.The arranged in the
Damit die Ventilscheibe 6 mit daran angeformtem Hohldorn 2.5 verdreht werden kann, wird zweckmäßigerweise ein Formschluss zwischen Siegel 3.2 und Hohldorn 2.5 dadurch ausgebildet, dass der Hohldorn 2.5 beispielsweise einen ovalen Querschnitt hat. Hierdurch kann durch Verdrehen des Medikamentenbehälters 3 in dem rohrförmigen Ansatz 2.3 auch die Ventilscheibe 6 in die Offen- oder Schließstellung verdreht werden.Thus, the
Bei den beschriebenen Ausführungsformen ist der Medikamentenbehälter 3 schräg zur Senkrechten in der Betriebsstellung an der Transferkappe 2 angesetzt, damit der Strömungsweg zwischen den beiden Hohldomen 2.4 und 2.5 möglichst kurz gehalten werden kann. Es ist aber auch möglich, die Transferkappe 2 auf der Seite des Medikamentenbehälters 3 breiter zu gestalten, so dass auch der Medikamentenbehälter 3 etwa senkrecht, also mit seiner Achse B etwa parallel zur Achse A des Infusionsbehälters 1 positioniert werden kann. Hierdurch ergibt sich zwar ein längerer Strömungsweg zwischen den beiden Hohldomen 2.4 und 2.5 mit dem zwischengeschalteten Ventil, der Strömungsweg kann aber so gestaltet werden, dass sich dadurch keine Störungen beim Zumischen des Medikaments ergeben.In the described embodiments, the
Bei einer solchen Ausgestaltung kann ein Ventilelement zwischen den beiden Hohldornen vorgesehen werden, das quer zu den Achsen A, B des Infusionsbehälters 1 und des Medikamentenbehälters 3 zum Öffnen und Verschließen der Verbindung zwischen den beiden Behältern in der Transferkappe 2 verschiebbar ist.In such an embodiment, a valve element between the two hollow mandrels can be provided, which is transversely displaceable to the axes A, B of the
Es ist auch möglich, die Transferkappe 2 zweiteilig derart auszubilden, dass auf den hohlzylindrischen Abschnitt 2.2 der rohrförmige Ansatz 2.3 mittels Rasten aufgesteckt wird. Hierdurch kann die Herstellung vereinfacht werden.
Bei dieser Ausführungsform nach
An dem hohlzylindrischen Abschnitt 2.2 ist der Hohldom 2.4 in entsprechender Weise an der Trennwand 2.7 angeformt, wie dies auch
Das Ventil in Form der Ventilscheibe 5 ist zwischen den beiden Elementen 2.2 und 2.3 zwischen den Trennwänden 2.7 und 2.51 eingeklemmt.The valve in the form of the
Bei der Ausführungsform nach den
Es ist auch eine Ausführungsform möglich, bei der die beiden Hohldome 2.4 und 2.5 an der Transferkappe 2 bzw. an deren Trennwand 2.7 angeformt sind, wobei der Ventilmechanismus seitlich zwischen die beiden Hohldome einsetzbar ist ähnlich der in
Der Siegelbereich 1.4 an der Entnahmeöffnung des Infusionsbehälters 1 kann so gestaltet sein, dass zwei nebeneinander liegende Siegelöffnungen 1.41 und 1.42 in der Kappe 1.3 vorhanden sind, von denen die eine für den Hohldom 2.4 der Transferkappe 2 und die andere für den Hohldom 4.1 der Tropfkammer 4 vorgesehen ist.
Bei einer solchen Ausgestaltung des Siegelbereichs kann an der Transferkappe 2 eine Ausrichteinrichtung angeformt sein, durch die die Transferkappe 2 nur so auf den Infusionsbehälter 1 bzw. auf die Siegelkappe 1.3 aufgesteckt werden kann, dass sich eine der Öffnungen 1.41, 1.42 unter der Ausnehmung 2.6 und die andere unter dem Hohldom 2.4 der Transferkappe befindet. Auf diese Weise wird eine Fehlpositionierung der Transferkappe 2 auf der Siegelkappe 1.3 verhindert.In such an embodiment of the sealing region, an alignment device can be integrally formed on the
Bei den beschriebenen Ausführungsformen sind der Medikamentenbehälter 3 und die Tropfkammer 4 so angeordnet, dass sie mit ihren Achsen im Wesentlichen in einer Ebene liegen, wie dies
Claims (10)
- Device for adding a medicine to an infusion solution in an infusion container (1), whose removal opening is provided with a seal area (1 4), comprising a cylindrical transfer cap (2),
which can be connected to the removal opening of the infusion container (1) and has a hollow spike (24) for piercing the seal area (1.4),
wherein a hollow cylindrical receiving means (2 3) for a medicine container (3) is formed at the cylindrical transfer cap (2) and has a hollow spike (2.5) for piercing a seal (3 2) at the medicine container (3),
a valve (5; 6; 7; 8) arranged between the two hollow spikes (2.4, 2.5) in the transfer cap (2),
wherein the valve interrupts the connection between the two hollow spikes (2 4, 2.5) and can be moved into the open position only by the action of a force, and
wherein a free area (2.6) is formed at the transfer cap (2) for attaching an infusion set, characterized in that
the hollow cylindrical receiving means (2 3) is arranged excentrically at the cylindrical transfer cap (2), wherein laterally adjacent the excentrically arranged hollow cylindrical receiving means (2.3), a recess (2 6) is formed at the transfer cap, into which the infusion set with a hollow spike (4.1) can be inserted by piercing vertically into the seal area (1 4) of the infusion container - Device according to claim 1, wherein the hollow cylindrical receiving means (2 3) is positioned with its axis (B) inclined to the axis (A) of the transfer cap (2), such that a medicine container (3) inserted in the receiving means (2.3) is arranged inclined to the axis (A) of the receiving means (2 3)
- Device according to claim 1 or 2, wherein the receiving means (2 3) for the medicine container (3) has a non-releasable connecting means
- Device according to one of claims 1 to 3, wherein the transfer cap (2) is formed in two parts and has a tubular hub (2.3) as a receiving means for the medicine container (3) and a hollow cylindrical portion (2.2) which via a locking means (2.32, 2.33) can be connected to the tubular hub (2.3) at which the hollow spike (2.5) is moulded on
- Device according to one of the preceding claims, wherein the valve is formed as a resilient valve disc (5) between the hollow spikes (2.4, 2.5) and provided with at least one slit which can be opened by pressure or low pressure
- Device according to one of claims 1 to 4, wherein the valve has a rotatable valve disc (6) which is provided with a passage opening (6 1), which by rotating can be aligned with the hollow spikes (2.4, 2.5) located opposite each other.
- Device according to one of claims 1 to 4, wherein the valve has a member (7) which is displaceable in the axial direction of the connection between the hollow spikes (2.4, 2.5) and by means of which a through-channel (2.52) can be sealed and unblocked
- Device according to one of claims 1 to 4, wherein the valve has a valve body (8) having a passage opening, the valve body being rotatable by an adjusting knob (8.1) and being arranged between the hollow spikes (2 4, 2 5) located opposite each other in the transfer cap (2).
- Device according to one of claims 1 to 3 and 5 to 8, wherein the hollow spike (2.5) provided for the medicine container (3) is inserted into the transfer cap (2) as a separate component part.
- Device according to claim 9, wherein at least members of the valve are moulded on or attached at the hollow spike (2.5)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200710046951 DE102007046951B3 (en) | 2007-10-01 | 2007-10-01 | Device for introducing a medicament into an infusion container |
| PCT/EP2008/008283 WO2009046903A1 (en) | 2007-10-01 | 2008-09-30 | Device for introducing medicine into an infusion container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2194951A1 EP2194951A1 (en) | 2010-06-16 |
| EP2194951B1 true EP2194951B1 (en) | 2014-02-26 |
Family
ID=40091757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20080802711 Active EP2194951B1 (en) | 2007-10-01 | 2008-09-30 | Device for introducing medicine into an infusion container |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8647320B2 (en) |
| EP (1) | EP2194951B1 (en) |
| CN (1) | CN101815496B (en) |
| BR (1) | BRPI0817631B8 (en) |
| DE (1) | DE102007046951B3 (en) |
| ES (1) | ES2464994T3 (en) |
| MY (1) | MY156061A (en) |
| RU (1) | RU2485930C2 (en) |
| WO (1) | WO2009046903A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102018110046A1 (en) | 2018-04-26 | 2019-10-31 | Henke-Sass, Wolf Gmbh | Transfer device for liquids |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
| US8974445B2 (en) * | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
| DE102009022417A1 (en) * | 2009-05-22 | 2010-12-30 | Fresenius Kabi Deutschland Gmbh | Drip chamber for an infusion device and infusion device with a drip chamber |
| IL201323A0 (en) | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
| US9981108B2 (en) | 2009-10-30 | 2018-05-29 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
| IL202070A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
| EP2462913A1 (en) * | 2010-12-10 | 2012-06-13 | Fresenius Medical Care Deutschland GmbH | Insert and vial for the infusion of liquids |
| DE102011004125A1 (en) | 2011-02-15 | 2012-08-16 | Robert Bosch Gmbh | Device for the hermetically sealed storage of liquids for a microfluidic system |
| USD737436S1 (en) | 2012-02-13 | 2015-08-25 | Medimop Medical Projects Ltd. | Liquid drug reconstitution assembly |
| IL219065A0 (en) | 2012-04-05 | 2012-07-31 | Medimop Medical Projects Ltd | Fluid transfer device with manual operated cartridge release arrangement |
| WO2014029433A1 (en) * | 2012-08-22 | 2014-02-27 | F. Hoffmann-La Roche Ag | Automatic device for transferring fluid |
| IL221635A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Drug vial mixing and transfer device for use with iv bag and drug vial |
| IL221634A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Universal drug vial adapter |
| WO2014041529A1 (en) | 2012-09-13 | 2014-03-20 | Medimop Medical Projects Ltd | Telescopic female drug vial adapter |
| USD734868S1 (en) | 2012-11-27 | 2015-07-21 | Medimop Medical Projects Ltd. | Drug vial adapter with downwardly depending stopper |
| JP6337080B2 (en) | 2013-03-14 | 2018-06-06 | リコール メディカル インコーポレイテッドReCor Medical, Inc. | Method for plating or coating an ultrasonic transducer |
| JP6322696B2 (en) | 2013-03-14 | 2018-05-09 | リコール メディカル インコーポレイテッドReCor Medical, Inc. | Ultrasound neuromodulation system |
| IL225734A0 (en) | 2013-04-14 | 2013-09-30 | Medimop Medical Projects Ltd | Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor |
| DK2983745T3 (en) | 2013-05-10 | 2018-10-22 | West Pharma Services Il Ltd | Medical devices comprising ampoule adapter with interconnected module for dry drug |
| USD765837S1 (en) | 2013-08-07 | 2016-09-06 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
| USD767124S1 (en) | 2013-08-07 | 2016-09-20 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
| JP3205560U (en) * | 2013-08-07 | 2016-08-04 | メディモップ・メディカル・プロジェクツ・リミテッド | Liquid transfer device for use with a drip liquid container |
| USD757933S1 (en) | 2014-09-11 | 2016-05-31 | Medimop Medical Projects Ltd. | Dual vial adapter assemblage |
| WO2016110838A1 (en) | 2015-01-05 | 2016-07-14 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage |
| US10357429B2 (en) | 2015-07-16 | 2019-07-23 | West Pharma. Services IL, Ltd. | Liquid drug transfer devices for secure telescopic snap fit on injection vials |
| USD801522S1 (en) | 2015-11-09 | 2017-10-31 | Medimop Medical Projects Ltd. | Fluid transfer assembly |
| CN108366905A (en) | 2015-11-25 | 2018-08-03 | 西部制药服务以色列有限公司 | Dual Vial Adapter Assembly Including Vial Adapter with Self-Sealing Inlet Valve |
| IL245800A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including identical twin vial adapters |
| IL245803A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter |
| IL246073A0 (en) | 2016-06-06 | 2016-08-31 | West Pharma Services Il Ltd | Fluid transfer devices for use with drug pump cartridge having slidable driving plunger |
| IL247376A0 (en) | 2016-08-21 | 2016-12-29 | Medimop Medical Projects Ltd | Syringe assembly |
| USD832430S1 (en) | 2016-11-15 | 2018-10-30 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblage |
| IL249408A0 (en) | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | A device for transporting fluids for use with an infusion fluid container and a hand tool similar to a plunger to release a vial from it |
| FR3060305B1 (en) * | 2016-12-16 | 2019-05-24 | Virbac Sa | DEVICE FOR COLLECTING A LIQUID CONTAINED IN A CONTAINER, CONTAINER AND USE THEREOF. |
| DE102017201755A1 (en) * | 2017-02-03 | 2018-08-09 | B. Braun Melsungen Ag | Penetration part for a medical infusion system, drip chamber and infusion system |
| IL251458A0 (en) | 2017-03-29 | 2017-06-29 | Medimop Medical Projects Ltd | User actuated liquid drug transfer devices for use in ready-to-use (rtu) liquid drug transfer assemblages |
| US11116696B2 (en) * | 2017-08-10 | 2021-09-14 | Baxter International Inc. | Reconstitution device, system, and method to administer a drug in a moderate bolus |
| IL254802A0 (en) | 2017-09-29 | 2017-12-31 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with twin vented female vial adapters |
| WO2019106642A1 (en) * | 2017-12-03 | 2019-06-06 | West Pharma. Services Il, Ltd | Liquid transfer device with telescopic vial adapter for use with infusion liquid container and discrete injection vial |
| USD903864S1 (en) | 2018-06-20 | 2020-12-01 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
| JP1630477S (en) | 2018-07-06 | 2019-05-07 | ||
| USD923812S1 (en) | 2019-01-16 | 2021-06-29 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
| JP1648075S (en) | 2019-01-17 | 2019-12-16 | ||
| PT3911292T (en) | 2019-01-18 | 2023-02-28 | West Pharma Services Il Ltd | Liquid transfer devices for use with intravenous (iv) bottles |
| CN113490477B (en) | 2019-01-31 | 2024-09-27 | 西医药服务以色列有限公司 | Liquid handling device |
| EP3924020A4 (en) * | 2019-02-15 | 2022-11-02 | Yukon Medical, LLC | TRANSFER DEVICE FOR USE WITH INFUSION FLUID CONTAINER |
| US12274670B2 (en) | 2019-04-09 | 2025-04-15 | West Pharma. Services IL, Ltd. | Liquid transfer device with integrated syringe |
| US11497684B2 (en) | 2019-04-16 | 2022-11-15 | Summit International Medical Technologies, Inc. | Reconstitution vial mixing apparatus |
| EP4360670A3 (en) | 2019-04-30 | 2024-07-17 | West Pharma Services IL, Ltd | Liquid transfer device with dual lumen iv spike |
| DE102020208146A1 (en) * | 2020-06-30 | 2021-12-30 | B. Braun Melsungen Aktiengesellschaft | Cap for medical fluid container, attachment part for cap, system comprising cap and attachment part, medical fluid container, system comprising medical fluid container and attachment part, method for producing a fluid container |
| USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3777587B2 (en) * | 1999-04-09 | 2006-05-24 | ニプロ株式会社 | Liquid container |
| US2816550A (en) * | 1955-11-14 | 1957-12-17 | Milton A Lapin | Dispensing cap |
| US2973758A (en) * | 1956-12-27 | 1961-03-07 | Invenex Pharmaceuticals | Apparatus for manufacturing parenteral solutions |
| US3828779A (en) * | 1972-12-13 | 1974-08-13 | Ims Ltd | Flex-o-jet |
| US3882909A (en) * | 1973-07-05 | 1975-05-13 | Ims Ltd | Trans-a-jet 1 |
| US3941171A (en) * | 1973-07-05 | 1976-03-02 | Ims Limited | Fluid transfer device |
| US3885607A (en) * | 1973-11-16 | 1975-05-27 | Richard I Peltier | Device for providing fluid communication between two sealed vessels |
| AR205565A1 (en) * | 1974-04-29 | 1976-05-14 | Abbott Lab | STORAGE AND TRANSFER UNIT FOR AN ADDITIVE PARTICULARLY APPLICABLE TO TRANSFER OF MEDICINES |
| US3938518A (en) * | 1975-01-15 | 1976-02-17 | Astra Pharmaceutical Products Inc. | Syringe attachment device |
| US4141379A (en) * | 1977-05-16 | 1979-02-27 | Cutter Laboratories, Inc. | Check valve |
| EP0005606A1 (en) * | 1978-05-12 | 1979-11-28 | Vishnu Shanker Shukla | Improvements in and relating to apparatus for administering intravenous drugs |
| US4434823A (en) * | 1981-06-29 | 1984-03-06 | American Hospital Supply Corporation | Liquid transfer device |
| NZ201330A (en) * | 1981-07-31 | 1985-07-12 | Alza Corp | Parenteral delivery system |
| US4392850A (en) * | 1981-11-23 | 1983-07-12 | Abbott Laboratories | In-line transfer unit |
| US4411662A (en) * | 1982-04-06 | 1983-10-25 | Baxter Travenol Laboratories, Inc. | Sterile coupling |
| US4623334A (en) * | 1983-03-07 | 1986-11-18 | Vanderbilt University | Intravenous drug infusion apparatus |
| US4820269A (en) * | 1983-03-07 | 1989-04-11 | Vanderbilt University | Mixer apparatus for controlling intravenous drug infusion |
| US4624667A (en) * | 1984-06-11 | 1986-11-25 | Abbott Laboratories | Additive transfer device |
| US4607671A (en) * | 1984-08-21 | 1986-08-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
| US4759756A (en) * | 1984-09-14 | 1988-07-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
| US5049129A (en) * | 1986-05-29 | 1991-09-17 | Zdeb Brian D | Adapter for passive drug delivery system |
| US4886495A (en) * | 1987-07-08 | 1989-12-12 | Duoject Medical Systems Inc. | Vial-based prefilled syringe system for one or two component medicaments |
| US4865583A (en) * | 1987-05-04 | 1989-09-12 | Tu Ho C | Combination blood sampling and intravenous infusion apparatus and method |
| JPH021277A (en) * | 1988-03-31 | 1990-01-05 | Fujisawa Pharmaceut Co Ltd | infusion container |
| US4898209A (en) * | 1988-09-27 | 1990-02-06 | Baxter International Inc. | Sliding reconstitution device with seal |
| US5304163A (en) * | 1990-01-29 | 1994-04-19 | Baxter International Inc. | Integral reconstitution device |
| US5308347A (en) * | 1991-09-18 | 1994-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
| CA2093560C (en) * | 1992-04-10 | 2005-06-07 | Minoru Honda | Fluid container |
| US6086560A (en) * | 1992-04-17 | 2000-07-11 | Science Incorporated | Fluid dispenser with fill adapter |
| JP2605345Y2 (en) * | 1992-05-01 | 2000-07-10 | 株式会社大塚製薬工場 | Drug container |
| JPH06239352A (en) * | 1993-02-05 | 1994-08-30 | Nissho Corp | Solution injection set |
| US5364386A (en) * | 1993-05-05 | 1994-11-15 | Hikari Seiyaku Kabushiki Kaisha | Infusion unit |
| DE69420240T2 (en) * | 1993-06-30 | 2000-04-20 | Baxter International Inc. | BOTTLE ADAPTER |
| US5334170A (en) * | 1993-07-14 | 1994-08-02 | Abbott Laboratories | Dye management system including an administration set with an in-line burette |
| US5397303A (en) * | 1993-08-06 | 1995-03-14 | River Medical, Inc. | Liquid delivery device having a vial attachment or adapter incorporated therein |
| US5647845A (en) * | 1995-02-01 | 1997-07-15 | Habley Medical Technology Corporation | Generic intravenous infusion system |
| FR2738550B1 (en) * | 1995-09-11 | 1997-11-07 | Biodome | DEVICE FOR SEALING A CONTAINER ITSELF CLOSED, ASSEMBLY FOR PROVIDING A PRODUCT COMPRISING SUCH A CONTAINER AND SUCH A SEALING DEVICE |
| US6277095B1 (en) * | 1995-10-11 | 2001-08-21 | Science Incorporated | Fluid delivery device with full adapter |
| US5833213A (en) * | 1995-12-29 | 1998-11-10 | Rymed Technologies, Inc. | Multiple dose drug vial adapter for use with a vial having a pierceable septum and a needleless syringe |
| US5893397A (en) * | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| DE19604113C2 (en) * | 1996-02-06 | 2000-10-26 | Schott Glas | Single-chamber transfer system for active substances, and the fully assembled transfer container |
| GB9611562D0 (en) * | 1996-06-03 | 1996-08-07 | Applied Research Systems | Device |
| US6036680A (en) * | 1997-01-27 | 2000-03-14 | Baxter International Inc. | Self-priming solution lines and a method and system for using same |
| US5807312A (en) * | 1997-05-23 | 1998-09-15 | Dzwonkiewicz; Mark R. | Bolus pump apparatus |
| US6090092A (en) * | 1997-12-04 | 2000-07-18 | Baxter International Inc. | Sliding reconstitution device with seal |
| US6209738B1 (en) * | 1998-04-20 | 2001-04-03 | Becton, Dickinson And Company | Transfer set for vials and medical containers |
| AR021220A1 (en) * | 1998-09-15 | 2002-07-03 | Baxter Int | CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER. |
| US7074216B2 (en) * | 1998-09-15 | 2006-07-11 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
| FR2783808B1 (en) * | 1998-09-24 | 2000-12-08 | Biodome | CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE |
| DE19927201A1 (en) * | 1999-06-15 | 2001-01-25 | Schott Glas | Syringe for medical purposes |
| US6719728B2 (en) * | 1999-06-16 | 2004-04-13 | Breg, Inc. | Patient-controlled medication delivery system with overmedication prevention |
| US6270481B1 (en) * | 1999-06-16 | 2001-08-07 | Breg, Inc. | Patient-controlled medication delivery system |
| IT1311347B1 (en) * | 1999-11-12 | 2002-03-12 | Borla Ind | CHECK VALVE FOR MEDICAL INFUSION LINES AND SIMILAR. |
| US6508791B1 (en) * | 2000-01-28 | 2003-01-21 | Ramon Guerrero | Infusion device cartridge |
| US6723076B1 (en) * | 2000-03-24 | 2004-04-20 | Michael Strobel | Animal drug delivery device |
| CN2452515Y (en) * | 2000-12-21 | 2001-10-10 | 黄红军 | Disposable syringe with contamination proof type medicine adding means |
| US6558365B2 (en) * | 2001-01-03 | 2003-05-06 | Medimop Medical Projects, Ltd. | Fluid transfer device |
| EP1264609B1 (en) * | 2001-06-06 | 2006-01-18 | Graziano Azzolini | High-sterility and high-capacity connector for lines for outflow from bottles |
| JP2003164508A (en) * | 2001-12-03 | 2003-06-10 | Taisei Kako Co Ltd | Transfusion container |
| US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
| HK1060819A2 (en) * | 2002-03-25 | 2004-07-23 | 陈永坚 | Personal care device |
| US8562583B2 (en) * | 2002-03-26 | 2013-10-22 | Carmel Pharma Ab | Method and assembly for fluid transfer and drug containment in an infusion system |
| US7744581B2 (en) * | 2002-04-08 | 2010-06-29 | Carmel Pharma Ab | Device and method for mixing medical fluids |
| US7867215B2 (en) * | 2002-04-17 | 2011-01-11 | Carmel Pharma Ab | Method and device for fluid transfer in an infusion system |
| EP1511528A4 (en) * | 2002-05-16 | 2008-07-02 | Scott Lab Inc | Drug container entry mechanisms and method |
| FR2867396B1 (en) * | 2004-03-10 | 2006-12-22 | P2A | PERFORATING PERFORMER WITH STERILE CONNECTION |
| US7935070B2 (en) * | 2005-01-28 | 2011-05-03 | Fresenius Medical Care North America | Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product |
| US7862539B2 (en) * | 2006-06-01 | 2011-01-04 | Codan Us Corporation | System and method for infusing toxins using safety set, connect set and cyto admin set |
| US20070282297A1 (en) * | 2006-06-01 | 2007-12-06 | Knight Thomas F | System and method for safely infusing toxins using extension set, connect set and cyto admin set |
| US8044778B2 (en) * | 2007-07-12 | 2011-10-25 | Henry Schein, Inc. | Injection device and case with reporting ability |
-
2007
- 2007-10-01 DE DE200710046951 patent/DE102007046951B3/en active Active
-
2008
- 2008-09-30 BR BRPI0817631A patent/BRPI0817631B8/en active IP Right Grant
- 2008-09-30 RU RU2010117377/15A patent/RU2485930C2/en active
- 2008-09-30 ES ES08802711T patent/ES2464994T3/en active Active
- 2008-09-30 CN CN200880109663XA patent/CN101815496B/en active Active
- 2008-09-30 US US12/680,734 patent/US8647320B2/en active Active
- 2008-09-30 MY MYPI2010001383A patent/MY156061A/en unknown
- 2008-09-30 WO PCT/EP2008/008283 patent/WO2009046903A1/en not_active Ceased
- 2008-09-30 EP EP20080802711 patent/EP2194951B1/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102018110046A1 (en) | 2018-04-26 | 2019-10-31 | Henke-Sass, Wolf Gmbh | Transfer device for liquids |
Also Published As
| Publication number | Publication date |
|---|---|
| US20110004184A1 (en) | 2011-01-06 |
| US8647320B2 (en) | 2014-02-11 |
| CN101815496B (en) | 2013-01-02 |
| RU2010117377A (en) | 2011-11-10 |
| BRPI0817631B8 (en) | 2021-06-22 |
| WO2009046903A1 (en) | 2009-04-16 |
| CN101815496A (en) | 2010-08-25 |
| RU2485930C2 (en) | 2013-06-27 |
| ES2464994T3 (en) | 2014-06-04 |
| DE102007046951B3 (en) | 2009-02-26 |
| BRPI0817631B1 (en) | 2019-06-25 |
| BRPI0817631A2 (en) | 2015-03-24 |
| EP2194951A1 (en) | 2010-06-16 |
| MY156061A (en) | 2016-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2194951B1 (en) | Device for introducing medicine into an infusion container | |
| DE69320400T2 (en) | Solvent container with means for connection to a drug vial | |
| DE69302933T2 (en) | Drug delivery system | |
| DE3709783C1 (en) | Dosing syringe | |
| DE3104861C2 (en) | ||
| DE69312366T2 (en) | Liquid container | |
| DE60013312T2 (en) | FUEL-ACTIVATED FLUID DISTRIBUTION VALVE | |
| DE2356397A1 (en) | FLUID TRANSFER DEVICE | |
| EP1713430A1 (en) | Medical transfer device | |
| EP1454650A1 (en) | Transfer device, in particular for medical fluids | |
| DE2902081A1 (en) | STOPPER FOR DRUG CONTAINER | |
| DE60007321T2 (en) | BOTTLE DISPENSER CAP | |
| DE2934334A1 (en) | CONTAINER SHELL CAP | |
| WO2022043446A1 (en) | Coupling device for an adapter for a vial, adapter for a vial, set comprising an adapter of this type, and system comprising an adapter of this type | |
| DE3627231A1 (en) | Transfer device for mixing of medicaments contained in different vessels | |
| EP1888423B1 (en) | Dispensing closure with a plug-through sleeve for fixing it to a container | |
| DE1750168C3 (en) | ||
| DE2121523A1 (en) | Aerosol container valve | |
| DE10351565A1 (en) | Self-closing fluid dispensing cap | |
| DE3703007A1 (en) | SECURITY CAPSULE WITH SEALING STRIPES FOR TANKED CONTAINERS | |
| DE2523717A1 (en) | INJECTION DEVICE | |
| EP2195075A1 (en) | Device for administering medical liquids | |
| WO2024023082A9 (en) | Closure system for a medicine container, and medicine container comprising a closure system | |
| EP0012445B1 (en) | Infusion device | |
| EP3458378A1 (en) | Container with a receiving area and method for removing a substance from the receiving area of a container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20100330 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61J 1/10 20060101ALN20130621BHEP Ipc: A61J 1/20 20060101AFI20130621BHEP |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20130905 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FREIGANG, HELMUT Inventor name: TITZE, JULIAN Inventor name: PROKSCH, KARL-HEINZ |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 653126 Country of ref document: AT Kind code of ref document: T Effective date: 20140315 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008011361 Country of ref document: DE Effective date: 20140410 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2464994 Country of ref document: ES Kind code of ref document: T3 Effective date: 20140604 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140226 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140526 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140626 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008011361 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20141127 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008011361 Country of ref document: DE Effective date: 20141127 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140930 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140930 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140930 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140930 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 653126 Country of ref document: AT Kind code of ref document: T Effective date: 20140930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140527 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20080930 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140226 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240930 Year of fee payment: 17 Ref country code: ES Payment date: 20241018 Year of fee payment: 17 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Free format text: CASE NUMBER: APP_5231/2025 Effective date: 20250131 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250919 Year of fee payment: 18 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20250923 Year of fee payment: 18 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20250922 Year of fee payment: 18 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20250922 Year of fee payment: 18 |